SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008791
Filing Date
2017-05-04
Accepted
2017-05-04 16:21:32
Documents
59
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mcrb-10q_20170331.htm 10-Q 1728254
2 EX-31.1 mcrb-ex311_9.htm EX-31.1 9927
3 EX-31.2 mcrb-ex312_6.htm EX-31.2 9914
4 EX-32.1 mcrb-ex321_7.htm EX-32.1 7634
5 EX-32.2 mcrb-ex322_8.htm EX-32.2 7645
  Complete submission text file 0001564590-17-008791.txt   5406841

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mcrb-20170331.xml EX-101.INS 1211212
7 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20170331.xsd EX-101.SCH 33827
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20170331_cal.xml EX-101.CAL 35765
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20170331_def.xml EX-101.DEF 73956
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20170331_lab.xml EX-101.LAB 253574
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20170331_pre.xml EX-101.PRE 187729
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 17814248
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences